News

Filter

Current filters:

Piramal Healthcare

1 to 9 of 10 results

India loses its attraction for pharma clinical trials, as domestic regulations tighten

India loses its attraction for pharma clinical trials, as domestic regulations tighten

27-01-2014

Considered a global clinical trial hub three years ago, India has suffered a series of setbacks, with…

Asia-PacificBioconIndiaPharmaceuticalPiramal HealthcareRegulationResearch

Piramal invests in UK ADC capacity

28-07-2013

India-based drugmaker Piramal Healthcare (BSE: 500302) says that it is to invest $2.5 million at its…

EuropeFinancialGenericsPiramal HealthcareProduction

Piramal buys molecular imaging portfolio from Bayer

16-04-2012

Indian drugmaker Piramal Healthcare (BSE: 500302) says it has signed an agreement to acquire worldwide…

BayerflorbetabenMergers & AcquisitionsPharmaceuticalPiramal Healthcare

Solvay costs and Meridia withdrawal take heavy toll on Abbott Labs 3rd-qtr 2010 results

21-10-2010

US health care major Abbott Laboratories (NYSE: ABT) posted disappointing financial results for the third…

Abbott LaboratoriesFinancialMeridiaPharmaceuticalPiramal HealthcareSolvay

Abbott Labs to buy Piramal domestic formulation business for $3.72 billion; to become number one drugmaker in India

21-05-2010

Fooling all the speculators, US health care major Abbott Laboratories has declared its intention to acquire…

Abbott LaboratoriesAsia-PacificGenericsMergers & AcquisitionsPharmaceuticalPiramal Healthcare

Sanofi-Aventis to take control of Poland’s Nepentes; cited as buyer for Piramal; names new chairman

19-05-2010

French drug major Sanofi-Aventis was in the limelight on several fronts in the last couple of days, two…

FinancialMergers & AcquisitionsNepentesPharmaceuticalPiramal HealthcareSanofi-Aventis

1 to 9 of 10 results

COMPANY SPOTLIGHT

Menarini

Back to top